文献速递肝病

免疫球蛋白G4相关硬化性胆管炎中核因子κB受体活化因子配体与髓源性抑制细胞活化的免疫生物学

The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid-Derived Suppressor Cell Activation in Immunoglobulin G4-Related Sclerosing Cholangitis.
PubMed 文献 · Hepatology · 2018-10-09

本研究利用IgG4相关硬化性胆管炎(IgG4-SC)患者大队列及原发性硬化性胆管炎、自身免疫性肝炎和健康志愿者对照,发现IgG4-SC患者血清和肝脏中RANKL表达显著增高,外周血MDSCs频率和数量显著增加,RANKL通过RANKL/RANK/NF-κB通路诱导MDSCs扩增和活化,经RANKL处理的MDSCs抑制T细胞增殖并诱导Th2分化。

要点

  • IgG4-SC患者血清和肝脏RANKL表达较肝病对照和健康对照显著增高。
  • IgG4-SC肝脏中RANKL分泌细胞与CD38阳性浆细胞及MDSCs共定位。
  • RANKL通过RANKL/RANK/NF-κB通路诱导MDSCs扩增活化并促进Th2型反应。

核心结论

  • 数据提示浆细胞来源的RANKL诱导MDSCs扩增和活化,后者抑制T细胞增殖并促进IgG4-SC特征性的Th2型反应。

研究设计与样本

  • 利用IgG4-SC患者大队列及原发性硬化性胆管炎、自身免疫性肝炎和健康志愿者对照研究MDSCs。

主要发现

  • IgG4-SC患者血清和肝脏中RANKL表达水平较肝病对照和健康对照显著增高。
  • IgG4-SC肝脏中RANKL分泌细胞与CD38阳性浆细胞及MDSCs(尤其单核细胞型MDSCs)共定位,并在肝脏表达RANKL受体。
  • 外周血MDSCs频率和数量显著增加。
  • 血清RANKL表达水平与血清γ-谷氨酰转移酶水平呈负相关,与MDSCs频率呈显著正相关。
  • RANKL通过RANKL/RANK/NF-κB信号通路诱导MDSCs扩增和活化,经RANKL处理的MDSCs抑制T细胞增殖并诱导Th2分化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The primary function of myeloid-derived suppressor cells (MDSCs) is reflected in their immune modulatory role in several immune-mediated diseases. In immunoglobulin G4 (IgG4)-related disease (IgG4-RD), it has been hypothesized that there are selective regulatory defects that lead to a T helper 2 (Th2) bias immune response. Herein we have taken advantage of a large cohort of patients with IgG4-related sclerosing cholangitis (IgG4-SC), the most common extrapancreatic involvement of IgG4-RD, as well as controls consisting of primary sclerosing cholangitis, autoimmune hepatitis, and healthy volunteers, to study MDSCs. We report dramatically increased levels of receptor activator for nuclear factor kappa B ligand (RANKL) expression in serum and liver from patients with IgG4-SC compared to both liver-disease and healthy controls. Moreover, in IgG4-SC liver, RANKL-secreting cells specifically colocalized with cluster of differentiation 38-positive plasma cells and MDSCs, particularly monocytic MDSCs, and express the RANKL receptor in liver. Similarly, the frequency and number of peripheral blood MDSCs were significantly increased. Importantly, serum expression levels of RANKL were inversely correlated with the serum level of gamma-glutamyltransferase but significantly positively correlated with the frequency of MDSCs. Moreover, we confirmed that RANKL induced the expansion and activation of MDSCs through the RANKL/RANK/nuclear factor kappa B signal pathway. Of note, RANKL-treated MDSCs suppressed T-cell proliferation and induced Th2 differentiation. Conclusion: Our data suggest that plasma cell-derived RANKL induces the expansion and activation of MDSCs, which suppress T-cell proliferation and contribute to the Th2-type response characteristic of IgG4-SC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lian M, Wang Q, Jiang X, et al. The Immunobiology of Receptor Activator for Nuclear Factor Kappa B Ligand and Myeloid-Derived Suppressor Cell Activation in Immunoglobulin G4-Related Sclerosing Cholangitis. Hepatology. 2018. PMID: 29774578. doi:10.1002/hep.30095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。